Advertisement

Avedro expands Riboflavin formulations for use in KXL System

05:00 EDT 12 Jun 2012 | Medical Business Review

Avedro, a global ophthalmic medical device and pharmaceutical company, has expanded its portfolio of proprietary riboflavin formulations for corneal collagen cross-linking.

Original Article: Avedro expands Riboflavin formulations for use in KXL System

NEXT ARTICLE

More From BioPortfolio on "Avedro expands Riboflavin formulations for use in KXL System"

Search BioPortfolio:
Advertisement
Advertisement